Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

SMTC, MSLP, SNPS, SAVW, AVGO - Market Update From DrStockPick.com!

drstock-2-3

signup3m

MusclePharm Corporation (OTCBB:MSLP) one of the fastest growing nutritional supplement companies in the United States, announced the appointment of Michael R. Stevens, PharmD as Director of Therapeutic Nutrition.

Dr. Stevens joins MusclePharm with over twenty years of well diversified experience in the healthcare and pharmaceutical industry. In addition to his current role as Chief Strategy Officer for Virostatics, Dr. Stevens spent 17 years at Bristol-Myers Squibb, where he held positions of increasing responsibility in the areas of Market Research (Oncology and HIV), Marketing (Oncology), and Medical Affairs (HIV).

"We are extremely pleased to have Dr. Stevens join the MusclePharm team and further strengthen our position in working to add MusclePharm's Re-con(NYSE:R) and MuscleGel(R) nutritional supplements to the New York State Medicaid list of prescription medications," commented Dr. Roscoe Moore, former United States Surgeon General, and Chief Science Director for MusclePharm. "With Dr. Stevens' extensive experience and assistance, we plan to further MusclePharm's support of therapeutic nutritional supplementation in the medical community."

Nutritional Supplementation has long been utilized within the HIV community to maintain and support muscle mass and help strengthen the immune system. Whey protein has been shown through various credible studies to aid in the growth of muscle mass. Unlike other Medicaid available proteins, MusclePharm's Re-con helps to burn fat while building muscle. This is a factor essential to people living with HIV, especially those on antiviral regimens where unwanted fat may be an issue in those who often battle muscle depletion.

*******************************************

http://pennyomega.com/img/savw.jpg

SavWatt USA, Inc. (OTC:SAVW), pioneers in LED lighting -- announced today the partnership with Pro-EcoSolutions. Under the agreement, Pro-EcoSolutions will be a subsidiary of SavWatt. Pro-EcoSolutions is a New Jersey based implementation firm specializing in comprehensive support services for all energy services companies and performance contractors. Pro-EcoSolutions provides a single source for project support and installation. The Company excels in identifying savings opportunities through the use of the most efficient energy technologies. Pro-EcoSolutions professionals will then develop design/build specifications, manage construction, and provide post-installation performance evaluations. Past clients include: Trump Plaza Hotel and Casino, Vitamin Shoppe, Albert Einstein Medical Center, Duane Reade, Radio City Music Hall, Loews Cineplex, Johnson & Johnson, Citibank Branches and others.

John Romano, President of Pro-EcoSolutions, commented, "Our association with SavWatt and their products will give our firm an advantage in the Energy saving environment. We are looking forward in this relationship and being able to provide our clients with quality LED products."

SavWatt is leading the LED lighting revolution and setting the stage to obsolete the incandescent light bulb through the use of energy-efficient, environmentally friendly LED lighting.

*******************************************

Avago Technologies Limited (Nasdaq:AVGO) announced on December 08, 2010, two new low-power optical sensors for wireless mouse applications. The ADNS-2080 and ADNS-3000 LED-based sensors leverage an advanced low-power architecture and automatic power management modes to enable over a year of battery life for cordless mice using a single AA battery. The ADNS-2080 and ADNS-3000 optical sensors provide precise, high-speed tracking for wireless mice, with high-speed motion detection of up to 30 inches per second (ips) and 20g acceleration detection. The sensors also feature selectable resolution of up to 2000 counts per inch (cpi) for highly accurate, sensitive navigation.

Avago Technologies Limited engages in the design, development, and supply of analog semiconductor devices worldwide. The company offers RF amplifiers, RF filters, RF front end modules, ambient light sensors, light emitting diodes, low noise amplifiers, mm-wave mixers, optical finger navigation, diodes, fiber optic transceivers, serializer/deserializer ASICs, motion control encoders and subsystems, optocouplers, and optical mouse sensors.

*******************************************

Synopsys Inc. (Nasdaq:SNPS) announced it has received the Corporate Award from the IEEE Standards Association (IEEE-SA) for its contribution to semiconductor and Electronic Design Automation (EDA) standards and its role in fostering innovation and collaboration in the standards community. The award is presented annually to an IEEE-SA member who demonstrates outstanding leadership and contributions to the organization.

Synopsys, Inc. and its subsidiaries provide electronic design automation software and related services for semiconductor design companies worldwide. It delivers semiconductor design and verification software platforms and integrated circuit (IC) manufacturing software products to the electronics market; intellectual property (NYSE:IP), system-level design hardware and software products, and design services; and software and services that help prepare and optimize designs for manufacturing.

*******************************************

Semtech Corp. (Nasdaq:SMTC) announced it has entered into an agreement in principle to settle all claims asserted against all defendants in the putative class action concerning the Company’s stock option accounting practices captioned In re Semtech Corporation Securities Litigation, Case No. 2:07-cv-07114-CAS (C.D. Cal). The agreement in principle provides for the payment of $20 million by the Company. The agreement in principle contemplates the negotiation and execution of a final settlement agreement. The proposed settlement would fully resolve all claims against the Company, all current officers and directors of the Company named in the lawsuit, and certain former officers and directors of the Company named in the lawsuit. No parties admit any wrongdoing as part of the proposed settlement. The settlement also is subject to preliminary approval by the Court, notice to the putative class and subsequent final approval by the Court.

Semtech Corporation, together with its subsidiaries, engages in the design, development, manufacture, and marketing of analog and mixed-signal semiconductor products. Its product lines include power management products comprising switching voltage regulators, combination switching and linear regulators, smart regulators, and charge pumps; protection devices consisting of filter and termination devices that provide protection for electronic systems from voltage spikes; and wired communication.

***************************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

drstbc

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer) .Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period.

Crown Equity Holdings Inc. (OTCPK:CRWE) has received five thousand dollars and anticipates receiving another forty five thousand dollars in cash from a third party for 30 (thirty) days of advertising for MusclePharm Corporation (OTCQB:MSLP).

Crown Equity Holdings Inc. (OTCPK:CRWE) has received five thousand dollars and anticipates receiving another forty five thousand dollars in cash from a third party for (thirty) days of advertising for SavWatt USA, Inc. (OTC:SAVW)